34652886|t|Suicide attempt induced by drug-induced leukoencephalopathy: A case report.
34652886|a|BACKGROUND: Leukoencephalopathy is identified during the administration of anticancer drugs. Symptoms vary from neurological symptoms to psychiatric symptoms depending on the site of damage. There have been no previous reports of suicide attempts due to drug-induced leukoencephalopathy. CASE PRESENTATION: The patient was diagnosed with diffuse large B-cell lymphoma (DLBCL) infiltrating the pharyngeal lesion. Rituximab + methotrexate + oncovin + procarbazine (R-MPV) therapy, a methotrexate-containing chemotherapy, was initiated. At the end of the fifth course, the patient attempted suicide by hanging with an appliance cord, which was associated with delusion. A head MRI scan showed no evidence of lymphoma recurrence, but white matter lesions around the ventricles showed progression. CONCLUSION: We report the case of a patient in whom drug-induced leukoencephalopathy related to methotrexate led to a suicide attempt. In addition to monitoring brain tumors, daily monitoring of psychiatric and neurological symptoms is important for patients with methotrexate-induced encephalopathy.
34652886	40	59	leukoencephalopathy	Disease	MESH:D056784
34652886	88	107	Leukoencephalopathy	Disease	MESH:D056784
34652886	188	209	neurological symptoms	Disease	MESH:D009461
34652886	213	233	psychiatric symptoms	Disease	MESH:D001523
34652886	343	362	leukoencephalopathy	Disease	MESH:D056784
34652886	387	394	patient	Species	9606
34652886	414	443	diffuse large B-cell lymphoma	Disease	MESH:D016403
34652886	445	450	DLBCL	Disease	MESH:D016403
34652886	469	486	pharyngeal lesion	Disease	MESH:D010608
34652886	488	497	Rituximab	Chemical	MESH:D000069283
34652886	500	512	methotrexate	Chemical	MESH:D008727
34652886	515	522	oncovin	Chemical	MESH:D014750
34652886	525	537	procarbazine	Chemical	MESH:D011344
34652886	539	544	R-MPV	Chemical	-
34652886	557	569	methotrexate	Chemical	MESH:D008727
34652886	646	653	patient	Species	9606
34652886	733	741	delusion	Disease	MESH:D063726
34652886	781	789	lymphoma	Disease	MESH:D008223
34652886	806	826	white matter lesions	Disease	MESH:D056784
34652886	905	912	patient	Species	9606
34652886	934	953	leukoencephalopathy	Disease	MESH:D056784
34652886	965	977	methotrexate	Chemical	MESH:D008727
34652886	1030	1042	brain tumors	Disease	MESH:D001932
34652886	1064	1075	psychiatric	Disease	MESH:D001523
34652886	1080	1101	neurological symptoms	Disease	MESH:D009461
34652886	1119	1127	patients	Species	9606
34652886	1133	1145	methotrexate	Chemical	MESH:D008727
34652886	1154	1168	encephalopathy	Disease	MESH:D001927
34652886	Positive_Correlation	MESH:D008727	MESH:D009461
34652886	Negative_Correlation	MESH:D000069283	MESH:D010608
34652886	Negative_Correlation	MESH:D008727	MESH:D010608
34652886	Cotreatment	MESH:D008727	MESH:D011344
34652886	Negative_Correlation	MESH:D011344	MESH:D016403
34652886	Positive_Correlation	MESH:D008727	MESH:D001523
34652886	Negative_Correlation	MESH:D014750	MESH:D010608
34652886	Negative_Correlation	MESH:D008727	MESH:D016403
34652886	Positive_Correlation	MESH:D011344	MESH:D063726
34652886	Negative_Correlation	MESH:D014750	MESH:D016403
34652886	Positive_Correlation	MESH:D008727	MESH:D001927
34652886	Cotreatment	MESH:D000069283	MESH:D008727
34652886	Cotreatment	MESH:D011344	MESH:D014750
34652886	Cotreatment	MESH:D000069283	MESH:D014750
34652886	Negative_Correlation	MESH:D011344	MESH:D010608
34652886	Cotreatment	MESH:D008727	MESH:D014750
34652886	Positive_Correlation	MESH:D014750	MESH:D063726
34652886	Negative_Correlation	MESH:D000069283	MESH:D016403
34652886	Cotreatment	MESH:D000069283	MESH:D011344
34652886	Positive_Correlation	MESH:D008727	MESH:D063726
34652886	Positive_Correlation	MESH:D008727	MESH:D056784
34652886	Positive_Correlation	MESH:D000069283	MESH:D063726

